Clinical trial
Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD
NCT00041483 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD
- Lead sponsor
- Alcon Research
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2002
- Completion date
- August 31, 2005
- Enrollment
- 530 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.